Results 81 to 90 of about 1,218 (152)

Impact of SGLT2 Inhibitors on Mortality Across Different Populations: A Systematic Review and Meta-Analysis. [PDF]

Int J Mol Sci
Movila DE, Motofelea AC, Dragan SR, Schiller A, Ionac A, Motofelea N, Caruntu F.   +6 more
europepmc   +1 more source

SGLT2 Inhibitors in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Tantush A, Ben Hamida B, Sagher M, Afsheen N, Sager M, Abusbaeh A, Tantoush M, Abusbaeh A, Najaim A, Alhamadi M, Hesham Gamal M, Alemam MM, Elhady MM.   +12 more
europepmc   +1 more source

Impact of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors on Nocturnal Polyuria: A Cross-Sectional Study. [PDF]

Cureus
Sato S, Yoshimura T, Komori K, Saheki T, Kobayashi T, Fukunaga K, Imachi H, Murao K.   +7 more
europepmc   +1 more source

Effects of Progranulin Deficiency on Inflammation and Fibrosis in the Kidneys and Liver of Diabetic Mice Fed a High-Fat Diet. [PDF]

Endocrinol Metab (Seoul)
Sakuma H, Murakoshi M, Hagiwara S, Shibata T, Suzuki Y, Gohda T.   +5 more
europepmc   +1 more source

Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima-Media Thickness in Patients With Cardiovascular Disease and/or Diabetes-A Systematic Review. [PDF]

Endocrinol Diabetes Metab
Shabu A, Naqvi SM, Hesari F, Naqvi SY, Tawfick W.   +4 more
europepmc   +1 more source

Pharmacokinetic Landscape and Interaction Potential of SGLT2 Inhibitors: Bridging In Vitro Findings and Clinical Implications. [PDF]

Pharmaceutics
Koo N, Lee EJ, Chang JE, Lee KR, Chae YJ.   +4 more
europepmc   +1 more source

SO019RENAL AUTONOMIC NERVES ARE RESPONSIBLE FOR BODY WEIGHT REDUCTION BY TOFOGLIFLOZIN [PDF]

Nephrology Dialysis Transplantation, 2016
openaire   +1 more source

Comparison of the efficacy of antidiabetic agents in type 2 diabetes with MASLD: a network meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Shao X, You J, Zhang H, Jiang X.
europepmc   +1 more source

A decade of SGLT2 inhibitors: Lessons learned and the road ahead in type 2 diabetes. [PDF]

J Diabetes Investig
Kimura T, Kaku K.
europepmc   +1 more source

Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. [PDF]

Hepatology
Qi X, Li J, Caussy C, Teng GJ, Loomba R.
europepmc   +1 more source